Submitted by Anonymous (not verified) on 26 March 2026 - 13:19
Orphan designation: zimberelimab Treatment of oesophageal cancer, 12/09/2025 Positive
Source:
Orphan designation: zimberelimab Treatment of oesophageal cancer, 12/09/2025 Positive